© All rights reserved to Barnea Jaffa Lande & Co. Law offices

Capital Markets / Shareholder Activism

Barnea is one of very few law firms in Israel that has played a role in shareholder activist matters.

Our team has led a number of high-profile local and cross-border challenges of control of Israeli incorporated public companies.

 

We represent activist investors and investment funds, advising them on a wide variety of activist strategies, including boardroom battles, hostile takeovers, and related court proceedings.

 

We have a proven track record in identifying opportunities for effecting change for our clients, in unlocking significant shareholder value, and in procuring settlements with these activist investors. 

 

At the same time, we understand the risks and challenges a company faces by having activist directors on its board. Thus, we assist publicly-listed and privately-held corporations in creating strategies for minimizing such risks, as well as prepare them for the possibility of an activist attack. We also provide ongoing advice to companies in defence against potential and current proxy fights or other shareholder activism.

 

Back to Capital Markets

News and updates - Capital Markets / Shareholder Activism:


March 26, 2019

Barnea Representing Knight Therapeutics in Minority Discrimination Lawsuit in Israel

Our firm is representing Knight Therapeutics, a Canadian public company that holds 28% of Israeli pharmaceutical company Medison's shares, in a lawsuit alleging the deprivation of its rights as a minority shareholder in Medison. The company is represented by Advs. Zohar Lande, Eyal Nachshon, Omer Keydar and Eitan Sivan of our Litigation Department.

November 6, 2018

The People Who Shake Management: 70% on Mellanox

Micky Barnea and Adv. Steve Wolosky are featured in a TheMarker profile about being the representatives of the American investment fund Starboard Value during its investment in Mellanox.

September 4, 2018

Activist Shareholders – The Israeli Challenge

Barnea and ACC hosted today a seminar on shareholder activism. Micky Barnea discussed activism in Israeli companies, while Noa Havdala lectured on activism in the courtroom. Also presenting were Elchanan (Nani) Maoz from Everest Fund and Steve Wolosky from Olshan Frome Wolosky LLP.

Capital Markets / Shareholder Activism

Barnea is one of very few law firms in Israel that has played a role in shareholder activist matters.

Our team has led a number of high-profile local and cross-border challenges of control of Israeli incorporated public companies.

 

We represent activist investors and investment funds, advising them on a wide variety of activist strategies, including boardroom battles, hostile takeovers, and related court proceedings.

 

We have a proven track record in identifying opportunities for effecting change for our clients, in unlocking significant shareholder value, and in procuring settlements with these activist investors. 

 

At the same time, we understand the risks and challenges a company faces by having activist directors on its board. Thus, we assist publicly-listed and privately-held corporations in creating strategies for minimizing such risks, as well as prepare them for the possibility of an activist attack. We also provide ongoing advice to companies in defence against potential and current proxy fights or other shareholder activism.

 

Back to Capital Markets

Key partner

P. Capital Markets, Corporate, Kibbutz Sector, Private Clients, Technology

News and updates - Capital Markets:


March 26, 2019

Barnea Representing Knight Therapeutics in Minority Discrimination Lawsuit in Israel

Our firm is representing Knight Therapeutics, a Canadian public company that holds 28% of Israeli pharmaceutical company Medison's shares, in a lawsuit alleging the deprivation of its rights as a minority shareholder in Medison. The company is represented by Advs. Zohar Lande, Eyal Nachshon, Omer Keydar and Eitan Sivan of our Litigation Department.

November 6, 2018

The People Who Shake Management: 70% on Mellanox

Micky Barnea and Adv. Steve Wolosky are featured in a TheMarker profile about being the representatives of the American investment fund Starboard Value during its investment in Mellanox.

September 4, 2018

Activist Shareholders – The Israeli Challenge

Barnea and ACC hosted today a seminar on shareholder activism. Micky Barnea discussed activism in Israeli companies, while Noa Havdala lectured on activism in the courtroom. Also presenting were Elchanan (Nani) Maoz from Everest Fund and Steve Wolosky from Olshan Frome Wolosky LLP.

Enter your email for newsletter sign up: